This brand name is authorized in Austria, Australia, Brazil, Cyprus, Estonia, Spain, Finland, France, Hong Kong, Ireland, Israel, Japan, Malta, Mexico, New Zealand, Poland, Singapore, Tunisia, Turkey, United Kingdom, South Africa
The drug BACTROBAN contains one active pharmaceutical ingredient (API):
1
Mupirocin
UNII RG38I2P540 - MUPIROCIN CALCIUM
|
Mupirocin is a novel antibiotic produced through fermentation by Pseudomonas fluorescens. Mupirocin inhibits isoleucyl transfer-RNA synthetase, thereby arresting bacterial protein synthesis. Mupirocin has bacteriostatic properties at minimum inhibitory concentrations and bactericidal properties at the higher concentrations reached when applied locally. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
BACTROBAN Nasal ointment | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
BACTROBAN 2% Cream | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
D06AX09 | Mupirocin | D Dermatologicals → D06 Antibiotics and chemotherapeutics for dermatological use → D06A Antibiotics for topical use → D06AX Other antibiotics for topical use |
R01AX06 | Mupirocin | R Respiratory system → R01 Nasal preparations → R01A Decongestants and other nasal preparations for topical use → R01AX Other nasal preparations |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: AU | Pharmaceutical Benefits Scheme | Identifier(s): 4348W, 4350Y, 9440W |
Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 510601301160316, 510614020051403 |
Country: EE | Ravimiamet | Identifier(s): 1110283, 1272743, 1865224 |
Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 58868, 59531 |
Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 545681, 568709 |
Country: FR | Base de données publique des médicaments | Identifier(s): 66325311 |
Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 138358, 142019, 142021, 161401, 165417, 165419, 29069, 29081, 29085 |
Country: HK | Department of Health Drug Office | Identifier(s): 28186, 33588 |
Country: IE | Health Products Regulatory Authority | Identifier(s): 13716, 13765, 13773, 36830 |
Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 976, 977 |
Country: JP | 医薬品医療機器総合機構 | Identifier(s): 6119700M1035 |
Country: MT | Medicines Authority | Identifier(s): MA192/02401, MA192/02402, MA192/02403, PI908/10601A |
Country: MX | Comisión Federal para la Protección contra Riesgos Sanitarios | Identifier(s): 037M86 |
Country: NL | Z-Index G-Standaard | Identifier(s): 13250728, 13577395 |
Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 21156, 32085 |
Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 4227 |
Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100008702, 100008719, 100098125, 100162952, 100241723, 100241746, 100272221, 100298717, 100298976, 100304398, 100324484, 100366146, 100384865, 100384888, 100394177, 100396816, 100399051, 100405053, 100421595, 100425185, 100427563, 100431820, 100437202, 100443740, 100459033, 100460327 |
Country: SG | Health Sciences Authority | Identifier(s): 00554P, 05075P, 11204P |
Country: TN | Direction de la Pharmacie et du Médicament | Identifier(s): 5143011 |
Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8699522355426, 8699522358014, 8699522385522, 8699522385539 |
Country: ZA | Health Products Regulatory Authority | Identifier(s): 34/20.1.6/0274, T/20.1.6/0075, W/20.1.6/218 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.